1. 3071 A phase II study of carboplatin (Cb), pemetrexed (PEM), and bevacizumab (Bev) followed by Bev and erlotinib (Erl) maintenance for non-squamous non-small cell lung cancer (NS-NSCLC) with wild-type (WT) EGFR. (September 2015) Authors: Takashina, T.; Asahina, H.; Yamada, N.; Harada, M.; Nakano, K.; Yokouchi, H.; Kanazawa, K.; Takamura, K.; Ogi, T.; Harada, T.; Honjo, O.; Morikawa, N.; Kinoshita, I.; Honda, R.; Amano, T.; Akita, H.; Isobe, H.; Nishimura, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inadvertent irreversible closure of arterial duct following therapeutic use of transplacental indomethacin in a fetus with severe Ebstein's anomaly and circular shunt. (1st December 2021) Authors: Gill, K.; Arbic, N.; Seed, M.; Honjo, O.; Ryan, G.; Jaeggi, E. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 58:Number 6(2021) Page Start: 940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗